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Introduction: Brazilian epidemiological studies on rheumatoid arthritis are scarce, mainly in
the  northeast; thus many data currently available originate from the international literature.
Objectives: To describe demographic, clinical and serological characteristics of patients with
rheumatoid arthritis (RA) followed-up by the same physician, in state of Piauí, Brazil.
Patients and methods: Data were collected between August 2010 and March 2013, in three
health services of Piauí that provided health care in Rheumatology: a university-afﬁliated
hospital, a public outpatient clinic and a private clinic.
Results: The numbers represent mean ± SD or percentage: 47.5 ± 11.03 years-old non-
Caucasian woman, non-smoker (59.2%), low educational level, mean disease duration of
7.7  years ± 7.6, and major extra-articular manifestations were rheumatoid nodules (19.4%)
and sicca syndrome (46.9%).
Conclusion: Features of rheumatoid arthritis obtained in this study are similar to those found
in  some national and international studies, but we observed higher female preponder-
ance and illiteracy rate, in addition to a moderately severe erosive disease on average, withfrequent sicca and other extra-articular manifestations.
© 2014 Elsevier Editora Ltda. All rights reserved.DOI of original article: http://dx.doi.org/10.1016/j.rbr.2014.02.005.
 Departure and institution where the study was originated: Hospital Getúlio Vargas, General Practice Department, Universidade Federal
do  Piauí.
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Características  demográﬁcas  e  clínicas  de  pacientes  com  artrite
reumatoide  no  Piauí,  Brasil  –  avaliac¸ão  de  98  pacientes
Palavras-chave:
Artrite reumatoide
Epidemiologia
Nordeste brasileiro
r  e  s  u  m  o
Introduc¸ão: São escassos os estudos epidemiológicos brasileiros sobre artrite reumatoide,
sobretudo no Nordeste; assim, muitos dados atualmente disponíveis têm sua origem na
literatura internacional.
Objetivos: Descrever as características demográﬁcas, clínicas e sorológicas de pacientes com
artrite reumatoide (AR) seguidos pelo mesmo médico no Estado do Piauí, Brasil.
Pacientes e métodos: Os dados foram coletados entre agosto de 2010 e marc¸o de 2013, em três
servic¸os  de saúde do Piauí com atendimento em reumatologia: um hospital universitário,
uma clínica ambulatorial pública e uma clínica privada.
Resultados: Os números representam média ± DP ou percentual: 98 pacientes com
47.5  ± 11.03 anos de idade; não-brancos; predominância de mulheres; não fumantes (59.2%);
baixo nível educacional; durac¸ão média da doenc¸a de 7.7 ± 7.6 anos; e as principais
manifestac¸ões  extra-articulares foram nódulos reumatoides (19.4%) e síndrome sicca (46.9%).
Conclusão: As características da artrite reumatoide obtidas neste estudo são similares àque-
las  encontradas em alguns estudos nacionais e internacionais, mas observamos maior
preponderância de mulheres, um nível de analfabetismo maior e, na média, uma  doenc¸a
erosiva moderadamente grave com presenc¸a frequente de sicca e de outras manifestac¸ões
extra-articulares.
© 2014 Elsevier Editora Ltda. Todos os direitos reservados.
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ﬁbrosis, pleuritis, interstitial changes, and/or rheumatoidntroduction
heumatoid arthritis (RA) is a chronic inﬂammatory disease
anifesting itself in various extra-articular signs and progres-
ive articular damage.1 Clinical onset of this disease may be
ariable; it generally begins with symmetrical involvement
f the small joints, pain, morning stiffness, and limitation
f movement  for more  than 1 hour. Although the meta-
arpophalangeal (MCP) joints, the proximal interphalangeal
PIP) joints, the wrists, the metatarsophalangeal (MTP) joints
nd the knee joints are the most frequently involved joints,
A may also involve other ones.
Rheumatoid arthritis affects approximately 0.5%-1% of
he population, and, although not directly life-threatening, it
auses a reduction in the patient’s quality of life and severe
conomic damages to society.2 It is more  prevalent in women
female/man ratio of 2:1), and its incidence increases with
ge.3
The incidence, severity, and outcome of the disease show
ariability between different ethnical-origin groups.4–6 This
ariability is related to the socioeconomic level and the
evel of development of countries, as well as genetic and/or
nvironmental factors. In underdeveloped countries, patients
ith RA are known to have a severe clinical course and
 poor prognosis due to limited access to the physician,
pecialist, and/or drugs. Studies on RA demonstrated that
ifferent genetic and/or environmental factors could impact
he disease in different ethnical groups. These studies sug-
est that RA patients, having different ethnic origin, may
xhibit different manifestations and outcomes, which enables
evelopment of different targeted treatment modalities. In
ur country, there is limited data about incidence, clinical
ourse, extra-articular symptoms, and outcomes of RA,7,8and there are few studies in Northeastern Brazil and no
study in Piauí. To meet this necessity, the present study was
designed to describe the demographic, clinical, and serological
characteristics of patients with RA followed-up by a physi-
cian.
Material  and  methods
Ninety-eight patients (87 women, 11 men) with RA diagnosed
according to the ACR classiﬁcation criteria ACR,9 between
August 2010 and March 2013, were included in the study.
The sample was chosen for convenience. Diagnosis, treat-
ment and monitoring of all patients were performed by the
same physician in a university-afﬁliated hospital, a public
outpatient clinic and a private clinic. Clinical history and phys-
ical examination of all patients were evaluated by a single
investigator. The following parameters were recorded in all
patients during the ﬁrst examination: demographic data, edu-
cational level, clinical ﬁndings, use of DMARDs, presence of
extra-articular symptoms, presence of concomitant comor-
bid diseases, laboratory parameters (including complete blood
count, rheumatoid factor [RF]) and radiological changes. Lung
involvement was determined by high-resolution CT (HRCT).
Erosive changes were detected on radiography by a rheuma-
tologist and a radiologist together, and they used Sharp
score.
Extra-articular symptoms were described as follows: (1)
sicca symptoms were the presence of dry mouth and
eyes, (2) pulmonary involvement was the presence ofnodule, (3) vasculitis was the presence of mononeuritis
multiplex, peripheral gangrene, deep ulcer, or histologi-
cal evidence. Diagnosis of the rheumatoid nodules was
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Table 1 – Demographics and disease characteristics of
the 98 patients with rheumatoid arthritis in Piauí, Brazil.
M:F 11:87
Mean age (years) 47.5 ± 11.03
Age group (years)
20-29 6 (6.12%)
30-39 16 (16.32%)
40-49 34 (34.69%)
50-59 32 (32.66%)
60-83 10 (10.21%)
Mean disease duration (years) 7.7  ± 7.6
Smoking
Smoking (present) 14 (14.3%)
Smoking (past) 25 (25.5%)
Non-smoking 58 (59.2%)
Medication for RA
Prednisone 30 (30.6%)
Methotrexate 39 (39.8%)
Antimalarial 30 (30.6%)
Leﬂunomid 14 (14.3%)
Table 2 – Educational level of patients in Piauí, Brazil.
Classiﬁcation n %
Illiteracy/incomplete elementary education 49 50.0%
Complete elementary education 13 13.3%
Incomplete secondary education 8 8.2%
Complete secondary education 15 15.2%
and followed-up by a rheumatologist. It was observed
that patients with RA have a similar clinical course and
Table 3 – Clinical and serological features of patients
with RA in Piauí, Brazil.
Main Features Frequency (%)
Sicca symptoms 46.9
Rheumatoid nodules 19.4
Respiratory symptoms
Dyspnea 19.4
Chest pain 12.2
Sputum production 10.2
Dry cough 11.2
HRCT 39.8
Lung involvement
Vasculitis 5.1
Raynaud phenomenon 3.1
Anemia 31.6
Erosion 62.2Anti-TNF- 03 (3.06%)
described as the presence of subcutaneous nodules >5 mm
on extensor surfaces of extremities. Normal ranges of
laboratory parameters were described as follows: ane-
mia  (hemoglobin < 11 g/dL), RF (normal <5 by nephelometry
method).
Informed consent was obtained. This study was approved
by the Committee on Ethics and Research of Universidade Fed-
eral do Piauí and has not conﬂict of interest.
Statistical  analysis
Data were inserted into Excel 2007 (Microsoft) sheets and
managed to provide the epidemiological proﬁle through
description and simple mathematical calculations, such as
percentage and arithmetic mean. Data was presented as
mean, SD and range for continuous variable, and percentages
for discrete variables.
Results
Of the 98 patients followed-up by the rheumatology clinic
and enrolled in the study, 87 were female, and 11 were male.
The mean age of patients was 47.5 years (ranging from 22 to
83 years), and mean duration of the disease was 7.7 years.
Thirty-one (31.6%) live in urban area and 67 (68.4%) in rural.
Thirty-ﬁve (35.7%) patients had respiratory symptoms, 14.3%
were current smokers, 59.2% were non-smokers, and 25.5%
had smoked in past (Table 1).
Data on education level are show in Table 2.
Six patients (6.1%) had diabetes mellitus. During the 3-year
follow-up, two patients died (one due to cerebral hemorrhage,
the other due to heart attack).
Thirty patients (30.6%) were taking oral steroids; 39 (39.8%)
were taking methotrexate (MTX); 30, hydroxychloroquine
(30.6%); 14, (14.3%) leﬂunomid; and 3 anti-TNF- (3.06%). Drug
history was difﬁcult to analyze, since the patients had taken aComplete higher education 13 13.3%
mean of 4 ± 1.3 second-line drugs for RA at the time of assess-
ment.
The sicca symptom (46.9%) was the most common extra-
articular involvement, and all patients fullﬁlled Sjögren’s
syndrome classiﬁcation criteria, followed by pulmonary
involvement (39.8%), vasculitis (5.1%), and the Raynaud’s phe-
nomenon (3.1%). Nineteen patients had rheumatoid nodules
(19.4%).
Thirty-one patients (31.6%) were detected to have anemia,
86.7% of the patients had positive RF, and 61 patients (62.2%)
had erosion (Table 3).
Sixty-three patients had no respiratory symptoms. Among
those with respiratory symptoms, cough (n = 21%-21.4%) was
the most common, followed by dyspnea (n = 19%-19.4%), and
chest pain (n = 12%-12.2%) (Table 3). Findings on HRCT were
rheumatoid nodule (12%), ﬁbrosis (32%), pleuritis (5%), and
interstitial changes (1%).
Discussion
Epidemiological studies on RA are mostly limited to developed
countries, and the incidence of RA in developing countries is
unknown.
The study investigated demographic, clinical, and sero-
logical data of Brazilian patients with RA born in PiauíRheumatoid factor 86.7
HRCT, High resolution CT.
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Table 4 – Comparison of the main features between patients with RA in different studies.
Features Badsha
et al.17
n = 100
Al-Salem
et  al.16
n = 100
Calgüneri
et  al.13
n = 526
Kobak S1
n = 165
Present
study
n  = 98
Female 87 89 453 125 87
Age (years) 42.2 39.1 48 52.5 47.5
RF positivity (%) 73 62 68.3 90.3 86.7
Erosions (%) 55.2 42 N 55.8 62.2
Sicca s/m (%) 28 14 11.4 40.6 46.9
R. nodules (%) 4  9 18.1 3.6 19.4
Lung involvement (%) n 7 4.8 6.6 39.8
RF, rheumatoid factor; Sicca s/m, sicca syndrome/manifestations; R. nodules, rheumatoid nodules.
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Table 4).
It is notable that the ratio female:male ratio of 8:1 in this
tudy was much higher than that reported in Western popula-
ions, but closer to some studies in developing countries. This
emale preponderance may be more  related to access clinical
r demographic factors or hormones. Table 5
The level of education of patients is consistent with the
esults found in Piauí population, and with the literature
howing that the disease is the most prevalent one in people
ith low education levels.
The pattern of involvement observed in our patients was
imilar to Caucasian and American patterns reported previ-
usly. The incidence of erosion was reported to be higher in
ur patients relative to Greek RA patients (29%).10
The most common extra-articular pattern, sicca com-
lex (46.9%), was similar to that observed in the Greek RA
atients.10 The study carried out in São Paulo has reported
oncomitance of that syndrome in 28% of the sample.11 It is
he most common ocular manifestation. Secondary Sjögren’s
yndrome is diagnosed according to the European criteria
odiﬁed by the American-European Consensus Group for Sjö-
ren’s syndrome in 2002.12
Sicca manifestations were observed in ophthalmologic
xam.
In Turkey, Calgüneri et al. evaluated extra-articular ﬁnd-
ngs of 526 RA patients followed-up by a single center.13 The
ost common extra-articular ﬁndings, including rheumatoid
odules (18.1%) and sicca symptoms (11.4%), were similar to
Table 5 – Comparison of the main features between patients wi
Features David et al.7
n = 38
Louzada
Junior et al.11
n = 1381
Female 32 1184 
Age (years) 
RF positivity (%) 68.4 71 
Erosions (%) 18.4 
Sicca s/m (%) 28 
R. nodules (%) 13.2 29 
Lung involvement (%) 15 those observed in some Mediterranean countries. In another
trial conducted in Turkey,14 in that 562 patients with RA were
evaluaed, eye involvement (8%) and subcutaneous nodules
(7.5%) were reported as the most common extra-articular
ﬁndings, and the rate of comorbid diseases was reported as
35.8%.
Positive RF rates detected in our patients were similar to
the results reported in the literature. Positive RF rates are
65%, 62%, and 60% in English, Malaysian and Kuwaiti patients,
respectively.15,16
The institution has resources for determining anti-CCP,
as well as the number of swollen joints and DAS-28, and a
measure of synthesis deﬁciency cannot be included in the
study.
Interestingly, the incidence of rheumatoid nodules was
only 19.4% in our patients, which is quite different from the
rate reported in the literature (30%). Calagüneri et al. reported
a similar incidence of rheumatoid nodules demonstrated in
Turkish patients (18.1%).13 Our values do not coincide with
that reported in the study carried out in São Paulo (29%).11
Type 2 diabetes mellitus was described in 6.1% of the
patients, a value similar to that of the general population
(7.6%; range, 5%-10%).18
Pulmonary manifestations were 39.8%, and that frequency
was greater than that reported in other studies (10%-20%).
A study carried out in São Paulo has reported a 15% fre-
quency. Pulmonary manifestations are believed to appear
within the ﬁrst ﬁve years after the diagnosis of RA. Although
pulmonary infections and/or pulmonary toxicity due to drugs
th RA in different studies in Brazil.
Mota et al.21
n = 65
Vaz et al.22
n = 19
Present study
n = 98
56 15 87
46 50 47.5
68 86.7
62.2
13.8 46.9
15.4 21 19.4
3.07 39.8
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are frequent complications, pulmonary disease directly asso-
ciated with RA is more  common. Although cardiovascular
diseases are responsible for most deaths related to RA,
pulmonary complications are common and directly respon-
sible for 10%-20% of the deaths directly attributed to
RA.19
All patients have received at least one of the DMARDs. The
ﬁrst choice of therapy was methotrexate (39.8%) and anti-
malarial (30.6%). However, only 14.3% of our patients have
received leﬂunomide, because the general health insurance
system in our country restricts usage of the drug. Only three
patients (3.06%) having persistent active disease refractory
to conventional DMARD treatment have received anti-TNF-
 therapy. This rate is 40%, and 54% for USA and France,
respectively.20
Less than 40% of patients are receiving methotrexate. The
inadequate treatment could have inﬂuenced the outcome of
the disease.
A variety of clinical presentations of RA observed in dif-
ferent populations and reported in the literature may be
associated with genetic and environmental factors. In our
country, there is a problematic situation resulting from the
small number of rheumatology centers available. Usually,
patients present to clinics at a late stage of the disease. The
socioeconomic level, noncompliance with treatment, and the
failure to attend the control visits are the factors that have an
impact on morbidity and mortality.
RA is a heterogeneous disease. It may exhibit different
clinical presentation in different populations. Since our trial
includes data from RA patients followed-up by a single cen-
ter, it cannot be representative of the whole population of
Piauí. To demonstrate the role of genetic and environmen-
tal factors, multicenter studies with a large patient sample
that includes the immune system and the HLA typing are
required.
Conclusion
We  can conclude that, in comparison with patients from West-
ern countries and other Brazilian studies, our RA patients were
characterized by a similar age at onset, but a higher female
preponderance, a higher illiteracy rate, and, on average, a mod-
erately severe erosive disease with frequent sicca and other
extra-articular manifestations.
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